Upload
phamdung
View
222
Download
2
Embed Size (px)
Citation preview
AUThOR INDEX
April 15, 1994
Agarwal, C., 2108
Albelda, S. M., 2055Ambrose, D., 2218Amin, K. M., 2055Anderson, K. C., 2234
Andersson, K. B., 2245Andrews, J. C., 2121Antoine, N., 2073Antoku, S., 2088Appel, M. J., 2113
Baserga, R., 2218Baylin, S. B., 2098Behrens, C. H., 2199Behrens, D. L, 2199Bénard,I., 2256Bevilacqua, P., 2251Blaese, R. M., 2141Blomhoff, H. K, 2245Bohlander, S. IC, 2060Bold, R. J.,2129
Bonilla, M. A., 2228Bosslet, K., 2151Brem, H., 2207Bull, J. M. C., 2223Burger, P. C., 2207
Cuban, M. A., 2207Calabretta, B., 2251Canete,A., 2228
Castello, M. A., 2251Castronovo, V., 2073Chauhan, D., 2234Chen, S-F., 2199Chen, Y-L., 2192Cheung, I. Y., 2228Cheung, N-K. V., 2228Chiang, Y., 2141Christoffersen, J., 2245Colvin, 0. M., 2207Coppes, M. J., 2077Coppola,D., 2218Croce, C. M., 2095Czech, J., 2151
Danhauser,L L, 2223Da Silva, J., 2256Davidson, B. L., 2055Daya-Makin,M., 2262Dc Roanne, C., 2073Dedrick, R. L, 2166del Mar Alonso, M., 2084Dexter, D., 2199Domb, A., 2207Dominici, C., 2251Dreyling, M., 2060Dvorak, H. F., 2269
Eck, S. L, 2055Eckert, R. L, 2108Ensminger, W. D., 2121
Felsani, A., 2251Ferrandis, E., 2256
Ferrando, A. A., 2091Fodstad, 0., 2146Fontasubre, B., 2064Frébourg,T., 2064Fredericks, J. R., 2199Freije, J. M. P., 2091FroSCM, G., 2064
Gabrielson, E., 2098Godal, A., 2146Greimers, R., 2073Gross, J. L, 2199Guo, J. W. H., 2186Gur, A., 2207
Hakomori, S-i., 2213Haldar, S., 2095Heinen, E., 2073Heller,G., 2228Hembree, J. R., 2108Hermonat, P. L., 2278Herndier, B. G., 2069Heya, T., 2160Hilton, J., 2207Hoffmann,D.,2151Hogg, J. C., 2262Hong, K., 2186Huang,A., 2186Huang,S. K., 2186Hunt, J., 2084Hwang, H. C., 2055
Igarashi, Y., 2213Ishizuka, J., 2129
Jenkins, 0. N., 2223Jeong, J. M., 2160
Kaiser, L R., 2055Kaneko, T., 2223Kawa, S., 2213Kharbanda, S. M., 2234Kim, S. S., 2240Kirshenbaum, M. R., 2199Knol, J.A., 2121
Kodama,T., 2136Kufe, D. W., 2234Kusaka, M., 2073Kushner, B., 2228
Larson, S. M., 2228Lawrence, T. S.,2121
12, N., 2160Lee, J. T., 2160Lee, Y. H., 2240Lehmann, M., 2102Un, K., 2269Lipp, M., 2262Ussitzky, J-C., 2102López-Otmn,C., 2091
Mabry,M.,2098Makino, M., 2223Malkin, D., 2077
Martinez, J., 2129Marvaldi, J., 2102McGrath, M. S., 2069Merlo, A., 2098Michot, J. P., 2064Miller, A. A., 2080Miyake, Y., 2136Mogentale, T. L., 2262Monne, M.,2095Morel, A. P., 2064Mueller, S. N., 2141Muindi, J. F., 2125Myklebust, A. T., 2146
Nagy, J. A., 2269Nakamura, K., 2088Negrini, M., 2095Negroni, A., 2251Neumann, R. D., 2160, 2166Noh, D-Y., 2240
Oberhammer, F., 2064Oldfield, E. H., 2141Olopade, 0. I., 2060Oshiro, E. M., 2141Ozturk, M., 2064
Paik,C. H.,2160
Papahadjopoulos, D., 2186Papp, L M., 2199Parchomchuk, J., 2262Park, J-G., 2240Park, K. J., 2240Park, Y. S., 2213Patten,A. D.,2199Pelech, S. L., 2262Phillips, T. L., 2186Pichon, J., 2102Polkus, S. T., 2199Ponchel, F., 2064Pucci, S., 2251Puisieux, A., 2064
Quaranta, V., 2102
Rabenandrasana, C., 2102Ram, Z., 2141Raschella, G., 2251Resnicoff, M., 2218Rigas, J. R., 2125Riou, G., 2256
Rodriguez, M., 2129Romeo, A., 2251Rorke, E. A, 2108Roulston, D., 2060Ruan, F.,2213
Rubin, R., 2218Rubini,M.,2218Rukstalis, D., 2060Ryu, S. H., 2240
Sabbioni, S., 2095Saga, T., 2160, 2166Sakaguchi, Y., 2223
Sanghera, J. S., 2262Scher, H. I., 2125Seitz, S. P., 2199
Sell, C., 2218Sexsmith, E., 2077Sherman, J., 2060Shiramizu, B., 2069Shockley, T. R., 2269Shridhar, V., 2084Sidransky, D., 2098Siegfried, J., 2084Simar, L. J., 2073Sipple, P., 2199Sladek, N. E., 2176Smeland, E. B., 2245Smith, D. I., 2084Smythe, W. R., 2055Sreerama, L., 2176Stadler, W. M., 2060Stafford, M. M., 2199Stauffer, P. R., 2186Stephens, L. C., 2223Stetson, P. L., 2121Stokke, T., 2245Strebel, F. R., 2223Suh, P-G., 2240Sukhatme, V. P., 2234Sun, J-H., 2199Sung, C., 2160, 2166
Tabone, E., 2064Tamura,R.,2102Taskén,K.,2245Thompson, J. C., 2129Tolley, E. A., 2080Townsend, C. M., Jr., 2129Tyler, B., 2207
Uchiyama, H., 2234Urla, J. A., 2091
van Garderen-Hoetmer, A., 2113van Osdol, W. W., 2166Velasco, G., 2091Viola, J. J., 2141Vollmer, R., 2098
Wagner,J.G.,2121Walbridge, S., 2141Walker, S. C., 2121Walter, K. A., 2207Warrell,R. P., Jr., 2125Weinstein, J. N., 2160, 2166Williams, B. R. G., 2077Wilson, J. M., 2055Woutersen, R. A., 2113Wu, R-T., 2192
Xu, H., 2269
Yamaguchi, K., 2136Yarmush, M. L., 2269Yeger, H., 2077Yeh, S. J., 2228Young, C. W., 2125
2285
Notification of Candidate
GUIDELINES FOR APPLICATION FOR ACTIVE ANDCORRESPONDING MEMBERSHIP
BENEFITS OF MEMBERSHIPA complete application consists of the following material:1. 6 copies of the form on the opposite side of this page, with all
requested information provided.2. 5 copiesof the candidate's most current curriculum vitae and
bibliography.3. 5 copiesof a letter of recommendationfrom a nominator who is
an active, corresponding, emeritus, or honorary member of theAACR (at least one copy must be a signed, original letter). Thisletter should describe the candidate's achievements in laboratoryresearch, clinical investigations, orepidemiological research, andit should affirm that this research adheres to accepted ethicalscientific standards. —OR—The nominator may supply theresponses requested at the bottom ofthe application form in thesection entitled “STATEMENT OF SUPPORT― (at least one copyof the form must be the signed original).
4. 5 copies of a letter of recommendation as described in Item 3above from a seconder who is an active, corresponding, emeritus,or honorary member of the AACR (at least one copy must be asigned, original letter). —OR—The seconder may supply theresponses requested at the bottom of the application form in thesection entitled ‘STATEMENTOF SUPPORT―(at least one copyof the form must be the signed original).
5. 5 reprints of each of two publications on which the candidateappears as author.All material should be collated into five complete sets with the
original application form as a covering document and sent to theaddress given below. Questions regarding procedures for membership application may also be directed to the following address:
American Association for Cancer ResearchPublic Ledger Building
620 Chestnut StreetSuite 816
Philadelphia, PA 19106-3483Phone: 215/440-9300FAX: 215-440-9313
RESPONSIBILITIES OF MEMBERSHIP
Candidates should be aware of the following responsibilities ofmembership in the AACR. Active members must pay annual dues,a major portion of which is designated for subscriptions to AACRpublications. In 1994 dues for active members are $150, $95 ofwhich is designated for journal subscriptions. Newly electedmembers of the AACR who have already purchased subscriptionsto Cancer Research, Cell Growth & Differentiation, or CancerEpidemiology, Biomarkers & Prevention at the higher, nonmemberrate will receive reimbursement of the unused portion of thosesubscriptions once their first year's membership dues are paid infull.
Corresponding members are required to pay dues ($65 in 1994)and may, if they wish, subscribe to Cancer Research, Cell Growth& Differentiation,or Cancer Epidemiology, Biomarkers & Preven
tion at reduced member rates.Applicants elected in March will be responsible for payment of
that year's dues; applicants elected in July and November will paydues for the following year. Applicants elected in March and Julywill be eligible to sponsor an abstract for the next annual meeting.Every effort will be made to afford the same opportunity toapplicants elected in November.
Margaret FotiExecutive Director
The American Association for Cancer Research (AACR), ascientific society consisting of laboratory and clinical cancerresearchers, was founded in 1907 to facilitate communication anddissemination of knowledge among scientists and others dedicatedto the cancer problem; to foster research in cancer and relatedbiomedical sciences; to encourage the presentation and discussionof new and important observations in the field; to foster publiceducation, science education, and training; and to advance theunderstanding of cancer etiology, prevention, diagnosis, andtreatment throughout the world.
Members of the AACR enjoy the following benefits:
1. subscriptions to all of the Association's high-quality journals,Cancer Research, Cell Growth & Differentiation, and CancerEpidemiology, Biomarkers & Prevention , at reduced memberrates;
2. the privilege of sponsoringa paper for presentationat the AACRannual meeting;
3. an advance copyof the scientific Program and the Proceedingsofthe American Association for Cancer Research for each annualmeeting;
4. reduced registration rates at all scientific meetings;5. priority notification of events in the AACR's outstanding series
of special conferences on timely subjects in the field;6. the receipt of AACR newsletters, meeting announcements,and
an up-to-date membership directory;7. reduced rates for the AACR Employment Register; and8. the professional benefits of AACR's public education activities.
QUALIFICATIONS FOR MEMBERSHIPActive membership in the AACR is open to investigators who
live in the Americas. Individuals who have conducted two years ofresearch resulting in peer-reviewed publications relevant to cancer,or who have made substantial contributions to cancer research inan administrative or educational capacity, are eligible. If acandidate is working in a research area not directly related tocancer but has conducted research of merit in a related area ofbiomedical science, he or she may also qualify for membership.
Corresponding membership is open to persons who are notresidents of the Americas. The qualifications for correspondingmembership are the same as those for active membership. Visitingscientists from outside the Americas who intend to return to theircountries of origin by the anticipated time of election should applyfor corresponding membership. All other visiting scientists shouldapply for active membership and transfer to corresponding statusat a later date upon leaving the Americas. Graduate and medicalstudents, postdoctoral fellows, and physicians in training who donot yet meet the above qualifications should apply for associatemembership.
PROCEDURES FOR APPLICATION
There are three deadlines for receipt of a membership application: January 1, May 1, and September 1 of each year. TheMembership Committee will review all complete applications foractive membership that have been received by these deadlines andwill submit recommendations on each candidate to the Board ofDirectors which formally elects all members. The same procedureis followed by the Special Memberships Committee which receivesapplications for corresponding membership. Candidates will benotified according to the following schedule:
Receipt of Application
in AACR Office _______________January 1May 1September 1
MarchJulyNovember
AMERICANASSOCIATIONFORCANCERRESEARCH
(City) (State/Province)
TELEPHONE NUMBER:___________________________(Country)
(Postal Code)
FAXNUMBER:_________________________E-MAILNUMBER
PRIMARY FIELD OF RESEARCH (Please check only one):Biochemistry and Biophysics Biostatistics
.......Cellular Biology and Genetics Clinical Investigations
......Epidemiology ....jmmunologyPreclinical Pharmacology and Virology
Experimental Therapeutics(CARRIER):____________________________________Carcinogenesis
..............EndocrinologyMolecular Biology and Genetics
Other:_________________________________(Pleasespecify)ACADEMIC
DEGREES (Including where and whengranted)EXPERIENCE
SINCE HIGHEST DEGREE WAS GRANTED (Please Iist most recent first)
DATE OF BIRTH:_________NAME OF CANDIDATE:LAST FIRST M.I.
PRESENT POSITION/TITLE:_
INSTITUTIONAL AFFILIATION:
INSTITUTIONAL ADDRESS:
PUBLICATIONS (Reprints of two peer-reviewed articles on which the candidate appears as an author must accompany thisapplication. For these two articles list the authors, title, journal, volume, inclusive pages, and year. Do not submit abstracts.)
CANDIDATENOMINATED BY*:
CANDIDATESECONDED BY*:
0 CORRESPONDING
(Please print)
MEMBERSHIP
(Please print)
0 ACTIVECANDIDATE IS APPLYING FOR (Check one):
STATEMENT OF SUPPORT (in place of letters of recommendation)Instead of submitting letters of recommendation, either the nominator or the seconder or both may complete the following section:
How long has the candidate worked in the field of cancerresearch? @@yearsWill the candidate make a long-term contribution to cancerresearch? Yes NoDoes the candidate's research adhere to accepted ethicalstandards? Yes NoI therefore recommend this candidate for membership in theAmerican Association for Cancer Research.
How long has the candidate worked in the field of cancerresearch? @@yearsWill the candidate make a long-term contribution to cancerresearch? _Yes _NoDoes the candidate's research adhere to accepted ethicalstandards? Yes NoI therefore recommend this candidate for membership in theAmerican Association for Cancer Research.
Date DateSignature of nominator* Signature of seconder*
See Guidelines for Application on the reverse side of this form for further instructions.
*Both nominator and seconder must be active, corresponding, emeritus, or honorary members of the AACR.
(This form may be reproduced.)
AMERICAN ASSOCIATION FOR CANCER RESEARCH, INC.Public Ledger Building - 620 Chestnut St. - Suite 816 . Philadelphia, PA 19106-3483
APPLICATION FOR ACTIVE OR CORRESPONDING MEMBERSHIP
@IDELINESFOR APPLICATION FOR ASSOCIATE MEMBERSHIP
signatures of both the candidate and the nominator. The application form may be submitted to the Association Office at any time.
After review of applications for associate membership, theExecutive Director will notify candidates of their election ordeferral within one month of the receipt of the application form.A check for one year's dues payment must accompany the application. Dues are currently $30 for associate members residing in theAmericas and $40 for residents of other countries. This fee will berefunded to any candidate deemed to be ineligible for associatemembership. Checks should be in U.S. currency, made payable toAACR, Inc., and drawn on a U.S. bank. Send the three copies ofthe application form and the $30 or $40 dues payment to:
American Association for Cancer ResearchPublic Ledger Building
620 Chestnut StreetSuite 816
Philadelphia, PA 19106-3483215/440-9300
RESPONSIBILITIES OF MEMBERSHIP
Associate members must pay annual dues in an amount to bedetermined by the AACR Board of Directors. Dues for 1993 and1994 have been set at $30 per year for residents of the Americasand $40 for residents of other countries. If an application issubmitted by August 31, the accompanying dues payment will becredited to the current year. Candidates submitting applicationsbetween September 1 and December 31 may indicate whether theywish their dues payments credited to the current or forthcomingyear. Candidates should be aware, however, that associatemembers may sponsor an abstract for the annual meeting only iftheir dues for the current year are paid. For example, an associatemember submitting an abstract in October 1993 for the forthcoming annual meeting must have paid dues for 1993. Any newlyelected associate members of the AACR who have already purchased subscriptions to Cancer Research, Cell Growth & Differentiation, and Cancer Epidemiology, Biomarkers & Prevention at thehigher, nonmember rate will receive a refund for the unusedportion of that subscription upon receipt of their payment for amember's subscription.
Each Fall the AACR will send to current associate members aninvoice for dues for the forthcoming year. Payment of this invoicemust be accompanied by a statement signed by the associatemember's current registrar, dean, or department head, verifyingthe member's current academic status. The Association's By-Lawsstate that dues are payable for each year in advance by January 1of the year to which they should be applied. An individual may bean associate member for a maximum of five years. Each year inwhich an individual pays dues will count as one full year ofassociate membership. Thus, an associate member who pays duesfor 1993 may retain associate membership until December 31,1997. The Board ofDirectors may terminate the membership of anassociate member whose dues are in arrears for two years.
Margaret FotiExecutive Director
AMERICAN ASSOCIATION FOR CANCER RESEARCH
QUALIFICATIONS FOR MEMBERSHIP
Associate membership is open to graduate students, medicalstudents, postdoctoral fellows, and physicians in training who arefollowing a course of study or who are working in a researchprogram relevant to cancer. Scientists in training who alreadyhave a substantial record of publications may wish to apply foractive or corresponding membership which confers full benefits ofmembership.
BENEFITS OF MEMBERSHIP
The American Association for Cancer Research (AACR), ascientific society consisting of laboratory and clinical cancerresearchers, was founded in 1907 to facilitate communication anddissemination ofknowledge among scientists and others dedicatedto the cancer problem; to foster research in cancer and relatedbiomedical sciences; to encourage presentation and discussion ofnew and important observations in the field; to foster publiceducation, science education, and training; and to advance theunderstanding of cancer etiology, prevention, diagnosis, andtreatment throughout the world. Associate members of the AACRenjoy the following benefits:
1. the privilege ofsponsoring a paper for presentation at the AACRannual meeting provided that (a) the associate member is thepresenter of the paper and (b) an active, corresponding, emeritus, or honorary member in good standing of the AACR alsosigns the abstract of the paper in support of the work (In thisinstance, the member who cosigns the abstract does not lose hisor her own sponsorship privilege.);
2. an advance copy of the scientific Program and (if one has beenpurchased by the associate member) the Proceedings of theAmerican Association for Cancer Research which containsabstracts of all papers being presented at each annual meeting;
3. the privilege of registering for the annual meeting at the lowstudent rate (This rate is otherwise available only to predoctoralstudents.);
4. preferred access to the AACR Employment Register;@ 5. optional subscriptions to the Association's high-quality journals@ Cancer Research, Cell Growth & Differentiation, and Cancer
Epidemiology, Biomarkers & Prevention at reduced member@ rates;@ 6. priority notification of events in the AACR's series of special@ conferences on timely subjects in the field;@ 7. reduced registration rates at special conferences;@ 8. the receipt of AACR newsletters, meeting announcements, and@ an up-to-date membership directory; and@ 9. the facilitation of informal scientific exchange with leading@ researchers in the cancer field.
@ PROCEDURES FOR APPLICATION
@ Persons wishing to apply for associate membership must use the@ official application form on the reverse side of these instructions.@ Each candidate for associate membership must be nominated by an@ active, corresponding, emeritus, or honorary member in good@ standing of the AACR. Three completed copies of the form should@ be submitted; at least one of these copies must carry the original
PNAME OF CANDIDATE:_________________________________________ DATE OF BIRTH:_________
LAST FIRST M.I.
(City) (State/Province)
TELEPHONE NUMBER:__________________________
PRESENT ACADEMIC STATUSPFITLE (Please check only one):............Graduate Student Medical Student
Physician in Training Postdoctoral Fellow
PRIMARY FIELD OF RESEARCH (Please check only one):..............Biochemistry and Biophysics Biostatistics
Cellular Biology and Genetics Clinical Investigations..Epidemiology lmmunology
Preclinical Pharmacology and VirologyExperimental Therapeutics
(Country) (Postal Code)
- FAX NUMBER:___________________
E-MAIL NUMBER (CARRIER):________________
Carcinogenesis....Endocrinology
Molecular Biology and GeneticsOther:
(Please specify)
ACADEMIC DEGREES (Please indicate degree(s) acquired to date along with the name of the academic institution and date ofreceipt. Provide information on degree currently being sought and the anticipated date of completion of this degree program.)
RELEVANT RESEARCH EXPERIENCE NOT RELATED TO COURSE WORK (Please list most recent first.)
PUBLICATIONS (List the authors, title, journal, volume, inclusive pages, and year of any article in a peer-reviewed journal onwhich the candidate appears as an author. Do not list abstracts. Continue on a separate sheet, if necessary.)
CANDIDATE NOMINATED BY:(Pleasetype or print name ofAACR active member in good standing.)
SIGNATURESI hereby apply for associate membership in the American Association for Cancer Research. I have read the instructions on thereverse side of this form, and I understand the privileges and responsibilities of this class of membership. I certify that thestatements on this application are true.
Signature of Candidate: Date:
I recommend this candidate for associate membership in the American Association for Cancer Research. To the best of myknowledge, the candidate is qualified for this class of membership, and the statements on this application are true.
Signature of Nominator*: Date:
Submit three copies of this form. At least one copy must contain the original signatures of the candidate and the nominator.Enclose a check in U.S. funds, made payable to AACR, Inc. , and drawn on a U.S. bank for one year's dues. Dues are currently $30for associate members residing in the Americas and $40 for residents of other countries.
Check one of the following boxes only if this form is being submitted between September 1 and December 31:The enclosed dues payment should be applied to the 0 current 0 forthcoming calendar year.
(NOTE: Ifdues are applied to the forthcoming year, membership will take effect on January 1, but the candidate will not be eligibleto sponsor an abstract for presentation at the annual meeting in May of that year.) See Guidelines for Application on the reverseside of this form for further instructions.
*Nominator must be active, corresponding, emeritus, or honorary member of the AACR.
(This form may be reproduced.)
AMERICAN ASSOCIATION FOR CANCER RESEARCH, INC.Public Ledger Building . 620 Chestnut St. . Suite 816 . Philadelphia, PA 19106-3483
INSTITUTIONAL AFFILIATION:
INSTITUTIONAL ADDRESS:
PLEASE FILL OUT ALL INFORMATION ON REVERSE SIDE AND SUBMIT THIS FORM WITH YOUR DISK.DISKS WILL NOT BE PROCESSEDWITHOUT THIS INFORMATION.
XyWnteIll Plus(for the IBM)WordPerfect4.2, 5.0, 5.1 (for the IBM)WordPerfect(fortheMac)Wordstar(fortheIBM)
Alsoacceptable:
AppleIIDOS3.3Applewith AppleworksSoftwareAppleIll PlusDOS3.3AppleMacIntosh400K Disc/
MacWrite2.2(text)AppleMacIntoshPlus800KDisc/
MacWrite 4.5 (text)cPT 8000DECWPS-.8DECDecmateIIDECDecmateIIIDisplay Write 3
Microsoft Word (for the IBM)MicrosoftWordMacintosh
(Versions 1—4)400/800KWangOIS(WPS)
Display Write 4IBMDisplaywriterWordProcessor6580LanierBusinessOneStepLanier No ProblemLanier Super No ProblemMASS-li PCMultimatePCWritePFSProfessionalWriteVolkswnter 4.0
New releases of word processing software are not always immediately available for conversion. In additiOn,because of the file structures and internal coding, we cannot accept disks created on desktop publishingsystemsor those created on proprietarytypesettingsystems.We also cannot guaranteethat all specialcharacterscanbetranslated.Tabularandmathematicalmaterial,suchasequations,willnotbecapturedfromthediskbutwillberekeyed.
To expeditework andfor your own security,we do requirethat you submita hardcopy printoutof the diskfile.Thetablesandequationswill be keyedfromthis hardcopy.Wealsoneedto knowthe nameof the file tobeconverted,the typeof hardware(e.g., IBMPC)on whichthefileswerecreated,theoperatingsystem(e.g.,DOS3.3),andtheversionof thesoftware(e.g.,WordPerfect5.1)usedtocreatethefile.
Guidelines for Submitting Disksto
American Association for Cancer Research Publications
Thewordprocessingpackagesthatwepreferareasfollows:
DISK SUBMISSION FORM
AACR joumals are now using personal computers to copyedit manuscripts accepted for publication. Whensubmittinga revisedmanuscript,authorsareencouragedto submitanelectronicdiskof thepaperalongwiththerequiredfourhardcopyprintouts.Diskswillultimatelyberetumedto theauthors.
I Seereverseforthewordprocessingpackagesthatcanbeaccepted.File preparation
Pleasebesurethatthefileyousendis themostrecentversionof themanuscriptandthat it matchesthemost recently submittedprinted copy. The file shouldcontain all the parts of the manuscriptin one file.Mathematicalandtabularmaterial,however,will be processedin the traditionalmannerandmaybeexdudedfromthediskfile.
Note:AACRdoesnot assumeresponsibilityfor errors in conversionof customizedsoftware,newlyreleasedsoftware,or specialcharacters.
Pleaselabel the outside of the disk with the joumal name, the first author's name,a partial title of themanuscript,andthenameof thecomputerfileusedto accessthemanuscriptondisk.Toprocessyourdiskefficiently,we needthe followinginformation.Pleasebesureto provideALL the information.
Nameusedto accesspaperondisk:Nameof computerused(e.g., IBM/PS2):Operatingsystem and version (e.g., DOS3.3):Wordprocessingprogramandversion(e.g.,WordPerfect5.0):
[See reverse for acceptable programs.]
Manuscript number:First author ________________________________________Correspondingauthor (if different from first author):Telephone/FAXnumbers:___________________________
This form (both sides) may be reproduced.
PUblished by
theAssoc1ahbo@'for
sear@cancerRe
SCOPE A DISTiNGUISHEDEDITORIALBOARD
Cell Growth &Differentiation (CG&D)
publishes significant, original research on
themolecularbiologyofcancer.Itsscopeencompasses in vitm and in vivo studies
pertainingto normal and abnormal cellular
processes.Topicsindude oncogenesand tumor
suppressor genes, gene expression and regula
tion, transcription factors, growth factors and
theirreceptors,molecularmechanismsoftumor progression, signal transduction, cell
cycle, differentiation, and development.
CG&D'sdistinguished, international Editorial
Boardhas recentlybeenexpandedtocoverthisbroadrangeofsubjectsevenmorecomprehensively.
In addition to original investigations, CG&D's
format includes Research Capsules which
summarizeandupdaterapidlychangingconcepts in the field and a Viewpointssection
for signed and anonymous write-in discussion
ofpublished articles.
INVITATiONTOAUTHORS
Send manuscripts to EditorialBoard
member ofyour choice. For details about
manuscript submission, contact:
[email protected],Editor-in-Chief301-846-1302,FAX3O1-696-1549,ortheAmericanAssociationforCancerResearch215-440-9300,FAX215-440-9355.
. Average peer reviewtime--2-3 weeks.
. Average time from acceptance to
publication--lO weeks.
. Indexed by ChemicalAbsfracts, Current
Contents, IndexMedicus, MEDLINE,
CancerLit, and BIOSIS Previews.
George F. Vande Woude
Edilor-in-Chief
MaiianoBarbacidMan Bernstein
MargaretE.BuckinghamWebster K.Cavenee
Jonathan Cooper
Suzanne Cory
SaraA.CourtneidgeTom Curran
François Cuzin
RobertEisenmanRaymond L. Erikson
MichaelM.GottesmanPeter Gruss
Nancy A.Jenkins
ORDER TODAY!
Volume 5, 1994 (12 issues)
ISSN 1044-9523
Rates in US $
$180Institutional$90IndividualnonmemberAdd$20fordeliveryoutsideUSCanadiansadd7%GST
Members, American Association
forCancerResearch:Forspecialrates, call 215-440-9300.
Orderby mail, phone, or FAX:
Cell Growth &Differentiation
do Williams&Wilkins428 East Preston Street
Baltimore, MD21202-3993
1-800-638-64231-800-638-4007 in MD
FAX:410-528-8596
FrankMcCormick
AndrewP.McMahonHarold L. Moses
Joseph R. Nevins
Yasutomi Nishizuka
Eric N. Olson
Luis F. Parada
Tony Pawson
GordonG.PetersHelen M. Piwnica-Worms
Joan V. Ruderman
JosephSchlessingerJames C. Smith
Bruce M. Spiegelman
CharlesD. Stiles
Tadatsugu Taniguchi
Sampk copy upon request
Cell Growth &DifferentiationA Journal of the Molecular Biology of Cancer
THESURGERYBRANCH,NATIONALCANCERINSTITUTE,NIH,ISSEEKINGPATIENTS FOR ONGOING CLINICAL TREATMENT PROGRAMS.
PATIENTS WITH THE FOLLOWING MALIGNANCIES
ARE BEING TREATED UNDER COMBINED MODALITY OR INNOVATIVE
IMMUNOTHERAPY PROGRAMS:
. METASTATIC MELANOMA AND KIDNEY CANCER.
. STAGE II OR LOCALLY ADVANCED BREAST CANCER.
. METASTATIC COLORECTAL CANCER TO THE LIVER.
. LOCOREGIONAL GASTRIC OR PANCREATIC CANCER.
. MESOTHELIOMA, PULMONARY METASTASES,
STAGE III A, B LUNG CANCER OR ESOPHAGEAL CANCERS
. LOCALIZED 50FF TISSUE SARCOMAS
. PERITONEAL CARCINOMATOSIS.
CARE FOR ALL PATIENTS IS PROVIDED AT THE CLINICAL CENTER, NIH,
BETHESDA, MARYLAND.
FOR MORE INFORMATION ON CANCER PROGRAMS, PLEASE CALL
(301)496—1533
NJh@flONALI ( ANGER
INSTITUTE
A Public Service Announcement Courtesy ofthis Publication
AACR SPECIAL CONFERENCE IN CANCER RESEARCH
OpeningLecturesDavidBaltimoreINewYorlçNYRobed TJIanI Berkeley,[email protected],Jr.I NewYork,NY
CellCycleandTranscrIptIon- IDavidM.LivingstonI Boston,MASt.ph.n J. EII.dg. I Houston,TXRobeit N. ElsenmanI Seattle,WACarol L Prlvn I NewYork,NY
CellCycleandTranscriptIon•IIGeorgeF.Vand.WoudeI Frede@ck,MDMarkKirechner!Boston,MASteven LReed I LaJolla,CA
SignalTransductIonSystemsInfluencIngTranscriptionJoan V. Rud.rman I Boston, MAMarcMontmlnyI LaJolla.CAJeanV.J.WangI LaJolla,CASpyridon Artavanls-TsakonesI NewHaven.CT
TranscrIptionFactorsControllingCellGrowthMIchaelKarinI LaJolla,CARIchardTreismanI London,EnglandMIchaelZ.GllmanI ColdSpnngsHarbor,NY
TranscriptionFactorsControllIngCellDifferentiation- IBrucePASplegelmanI Boston,MAElaIneV.FuchsI Chicago,ILMichaelC. RosenfeldI LaJolla,CAMichaelLevineI LaJ@ CA
TranscrIptionFactorsControllIngCeODifferentiation•IIEric N.Olson I Houston,TXStuartOrklnI Boston,MACharles P. Emerson I Philadelphia, PA
DevelopmentEddyM.DeRobertlsI LosAngeles,CARIchardBehrlngerI Houston,TXJanetRossantIToronto,Ontario,CanadaCliffordTablnI Boston,MA
Applicantsare encouragedto submitabstractsforposterpresentation.
Information and Application Forms
AmericanAssociationfor CancerResearchPublicLedgerBuilding620 Chestnut Street, Suite 816Philadelphia,PA 19106(215) 440-9300 (215) 440-9313 (FAX)ApplicatIonDeadline:June27,1994
TranscriptionalControlofCellGrowthandDifferentiation
October16-20,1994ChathamBarsInn,Chatham(CapeCod),Massachusetts
CONFERENCECHAIRPERSONS
EricN.OlsonI Houston,TXBruceM.SplegelmanI Boston,MA
PROGRAMCOMMITTEE
ElaIneV.FuchsI Chicago,ILJoanV. RudermanI Boston,MA
SCIENTIFICPROGRAM
A Pubhcaton of the Amer@can Association for Cancer Research@ Co-sponsored by the American Society of Preventive Oncology
Editor-in-Chief
Pt.I@t\()(oirca
Associate Editors
\\ . RohurtFtriicc
\Vchstcr K.Caveucu
jO@ef)h F. Fr@ttlll1el1i. .@
LilullR. (‘lit!
(;iiiis C. harris
Frederick P. Li
\\ . ht1Ol1l:t@1,011(1011
‘FlioulasE. \lOOll
.@f)raIlaI11\l.i. \Ol11tlr@t
@tl11e5\@Swellhel't.
Steven R. ldllllellf)t11Ill
.@1iceS.\\ tiitteiilorc\lillli C. \ti
(:@i@icer/:/ideinialoçi'. /3lOflhiI!k('I@V&
@ 1)t11)11S11(Soriginal rcscarcli Oil
CdilCC@C@fll@dtiOil@Lil(lPr(\(1lti@il ill Ilt1ill@tilS.
thu foIIo@@log tO1)iC@@LI(Of @I)(CitIiiltcicst:
(lCSCflj)tIVC.ailal\tiCaI. I)U)CllCilliCaI@til(l
illoiccillar@ : tllc USCof l)ioilla.rkcrs
to studs tllc IlCOI)I@LStiC@Lil(lPr11l@@PIastic
P!@C@SS(Sill IuIill@Lils:chcilloprc\ ciltioll @1il(l
OthC! t\@ of )iC\ (iltR)fl trials: @til(ltllC rOtC
of l)CIl@L\ioi@tIfactors ill CaI1CCI(tiOIOg\aIl(l
t)rC\ CfltR)il.
l@titictiIai @tttCIltU)ilC @I\Cil to tlit i(lCiltifiC@t—
10)11of factors @LSSOChLtCd@vithvarious @tSt)CCts
of tllu carcinogenic @[email protected]
StIS('(1)tiI)iIit\@ tU)St factors. iIlfCCtU)tIS @tg(IltS.
CtlCilliCdI @Lil(lj)tl\ Si('dI carcinogens. cin'iron
illCilt@LICOilt@Lilliil@tilt@.(lictdr\ COillf)OIlCiltS
@LIl(lI)C11d\ioi@Ifactors @ticlias tOb@LCC()usc
@1Il(lStill (\P@stlr@.
Signitic@tot.( ligi oat rc@carcIluicctillg thu
IligliusI sciciititic st@Lll(Ltl(1sis iu@itud for
@.,1l1)111ISSIOI1.
For 111)11illf()lIUItR)li.COllt@LCt: l)i. PCLI\()
(;@r@@t.l@titor—iu—Ctlicf(SO-i) 52@)—2@@@.
l:.@x(@)@)@
R@tpklrc@ic@t)r@C@@51\P((titC(l h\I:@x
Pl( )ll1Pt )ti 1)1iCttU)l1 of @icccptcdf)@Lf)l@
IllilC\C(l f)\ (‘hem/cal@ l/)ctraCI.c.(‘,,r,v,it
(‘wiIe@its(@lI. I1l(1t@\•JIUIkhIS@,@tll(t.@lEI)Jt\L
\OItllllC 3, 199-i (S issues)
ISS\ lO@-996S
Ratus iu t:s S
SI @Slustitutiotial@ Ill(li\ (that 11011I11CI1l1)Cr
@(l(lS2()forde1iver@otitsidcES(:Llladlaus ad(I 7 GS'l'
\lculhcrs. .\iiicricau .@ssOCiatiOll
for (;@tI1c(@rResearch (:@@CR)ald
.@ll1crical1Societ\ of Prcvcllti\ 1
Oucolog\ (ASPO) : (olltacl \ our
sOCiCt\ for sPecial rates.
Ordur I)\ ulail. Pll@[email protected] F.\@\:
(aiieei l;/ideiniaIo@ç;y.
l@ioiiui,kei@c&Preientioii
(@ 0 \\ iIIi@t1ll5& \\ilkiiis
-t25 EastPrestonStreet
Raltullore, \lI) 21202-3993
I-@00-638-6@i23
I—@00-63@—400@'ill \lI)
1@\:-@l0-528-SS9( Sample copy upon request
8 ISSUES IN 1994(previously 6 issues/year)
. More up-to-the-minute
informationthaneverbefore.
S Contains original research,invited editorials, selectedreviews,meeting reports,shortcommunications, AACR and
ASPOnews.
. March issue includes
abstracts from ASPO meeting.